SciClone Pharmaceuticals (Holdings) Limited

SHSC:6600 Voorraadrapport

Marktkapitalisatie: HK$11.4b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

SciClone Pharmaceuticals (Holdings) Beheer

Beheer criteriumcontroles 3/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Hong Zhao

Algemeen directeur

CN¥17.0m

Totale compensatie

Percentage CEO-salaris45.0%
Dienstverband CEO4yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijn2yrs
Gemiddelde ambtstermijn bestuur3.3yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Hong Zhao's beloning veranderd ten opzichte van SciClone Pharmaceuticals (Holdings)'s winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Dec 31 2023n/an/a

CN¥1b

Sep 30 2023n/an/a

CN¥1b

Jun 30 2023n/an/a

CN¥953m

Mar 31 2023n/an/a

CN¥904m

Dec 31 2022CN¥17mCN¥8m

CN¥855m

Sep 30 2022n/an/a

CN¥844m

Jun 30 2022n/an/a

CN¥833m

Mar 31 2022n/an/a

CN¥878m

Dec 31 2021CN¥26mCN¥7m

CN¥923m

Sep 30 2021n/an/a

CN¥837m

Jun 30 2021n/an/a

CN¥779m

Mar 31 2021n/an/a

CN¥766m

Dec 31 2020CN¥29mCN¥7m

CN¥754m

Sep 30 2020n/an/a

CN¥817m

Dec 31 2019CN¥15mCN¥6m

CN¥615m

Compensatie versus markt: Hong's total compensation ($USD2.35M) is above average for companies of similar size in the Hong Kong market ($USD480.51K).

Compensatie versus inkomsten: Hong's compensation has been consistent with company performance over the past year.

CEO

Hong Zhao (61 yo)

4yrs

Tenure

CN¥17,030,000

Compensatie

Mr. Hong Zhao has been President and Chief Executive Officer at SciClone Pharmaceuticals (Holdings) Limited since June 24, 2020 and also serves as its Executive Director since June 24, 2020. Mr. Zhao serve...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Hong Zhao
CEO, President & Executive Director4yrsCN¥17.03m0.18%
HK$ 20.6m
Rongrong Pan
Company Secretaryless than a yeargeen gegevens0.026%
HK$ 3.0m
Chihwen Shao
VP & Head of Technical Operations and Pharmacovigilance2.4yrsgeen gegevensgeen gegevens
Min Jia
VP & Head of Immunization Business Unitno datageen gegevensgeen gegevens
Mingxiang Wu
VP and Head of Market Access & Commercial Operation (MACO) Departmentno datageen gegevensgeen gegevens
Lianzong Wu
VP and Head of Registration & Pharmaceutical Affairs Departmentno datageen gegevensgeen gegevens
Li Mao
VP, GM of Research and Development & Chief Medical Officer2yrsgeen gegevensgeen gegevens
Min Wu
VP & Chief Business Development Officerless than a yeargeen gegevensgeen gegevens

2.0yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: 6600's management team is considered experienced (2 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Hong Zhao
CEO, President & Executive Director4yrsCN¥17.03m0.18%
HK$ 20.6m
Rongrong Pan
Company Secretary1.1yrsgeen gegevens0.026%
HK$ 3.0m
Daniel Vasella
Non-Executive Director3.8yrsCN¥658.00kgeen gegevens
Guoen Liu
Independent Non-Executive Director3.3yrsCN¥658.00kgeen gegevens
Zhenfu Li
Non-Executive Chairman4yrsgeen gegevensgeen gegevens
Wendy Hayes
Independent Non-Executive Director3.3yrsCN¥658.00kgeen gegevens
Haixia Wang
Non-Executive Director3yrsgeen gegevensgeen gegevens
Yi-Hsien Lin
Non-Executive Director3.3yrsgeen gegevensgeen gegevens
Ping Chen
Independent Non-Executive Director3.3yrsCN¥658.00kgeen gegevens
Yushao Gu
Independent Non-Executive Director3.3yrsCN¥658.00kgeen gegevens

3.3yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: 6600's board of directors are considered experienced (3.3 years average tenure).